- call +1-201-465-4211
- email sales@mrinsights.biz
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
Scope of the Report:
This report studies the Hospital-Acquired Disease Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital-Acquired Disease Testing market by product type and applications/end industries.
The increasing incidence of hospital acquired infections (HAI) is one of the key factors propelling the global hospital acquired disease testing market. For the prevention of these infections many countries such as the U.S. have issued rules and regulations to be mounted in the hospitals and clinics. For instance, the U.S. has regulated HHS Action Plan to reduce infections auqired in hospitals. These government plans and movements and increasing investments are expected to poise to growth of the global market of hospital acquired disease testing. Furthermore, the rising number of pathogens with drug-resistant abilities is foreseen to help the market expand. Numerous hospitals around the world are facilitating the pathogen detection procedures with improved surveillance culture. To prevent the transmission of diseases, various health organizations are demanding for effective hospital acquired disease testing solutions.
The majority of regulations regarding molecular-biology-based diagnostics remain un-updated, which can act as a restraining factor. Furthermore, the absence of control authorities and efficient control programs in less developed countries could hinder the market growth. For instance, African countries such as Nigeria do not have any effective programs or authority to prevent or control hospital acquired diseases.
North America has the largest share in this market followed by Europe. Due to the increase in medical tourism industry in Asian countries, the Asia-Pacific market is expected to flourish in the forecasted period.
The global Hospital-Acquired Disease Testing market is valued at 520 million USD in 2017 and is expected to reach 700 million USD by the end of 2023, growing at a CAGR of 5.1% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital-Acquired Disease Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Diatherix Laboratories
Gen-Probe
Qiagen
F. Hoffmann-La Roche
Cepheid
Life Technologies Corporation
Meridian Biosciences
Cantel Medical Corporation
Nordion
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
UTI Testing
SSI Testing
Pneumococcal Infections Testing
Bloodstream Infections Testing
MRSA Testing
Market Segment by Applications, can be divided into
Small and Medium Sized Hospitals
Large Sized Hospitals
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Hospital-Acquired Disease Testing Market Overview
1.1 Product Overview and Scope of Hospital-Acquired Disease Testing
1.2 Classification of Hospital-Acquired Disease Testing by Types
1.2.1 Global Hospital-Acquired Disease Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Types in 2017
1.2.3 UTI Testing
1.2.4 SSI Testing
1.2.5 Pneumococcal Infections Testing
1.2.6 Bloodstream Infections Testing
1.2.7 MRSA Testing
1.3 Global Hospital-Acquired Disease Testing Market by Application
1.3.1 Global Hospital-Acquired Disease Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Small and Medium Sized Hospitals
1.3.3 Large Sized Hospitals
1.4 Global Hospital-Acquired Disease Testing Market by Regions
1.4.1 Global Hospital-Acquired Disease Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hospital-Acquired Disease Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hospital-Acquired Disease Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital-Acquired Disease Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hospital-Acquired Disease Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital-Acquired Disease Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Hospital-Acquired Disease Testing (2013-2023)
2 Manufacturers Profiles
2.1 Diatherix Laboratories
2.1.1 Business Overview
2.1.2 Hospital-Acquired Disease Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Gen-Probe
2.2.1 Business Overview
2.2.2 Hospital-Acquired Disease Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Gen-Probe Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Qiagen
2.3.1 Business Overview
2.3.2 Hospital-Acquired Disease Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Qiagen Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 F. Hoffmann-La Roche
2.4.1 Business Overview
2.4.2 Hospital-Acquired Disease Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Cepheid
2.5.1 Business Overview
2.5.2 Hospital-Acquired Disease Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Cepheid Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Life Technologies Corporation
2.6.1 Business Overview
2.6.2 Hospital-Acquired Disease Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Meridian Biosciences
2.7.1 Business Overview
2.7.2 Hospital-Acquired Disease Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cantel Medical Corporation
2.8.1 Business Overview
2.8.2 Hospital-Acquired Disease Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nordion
2.9.1 Business Overview
2.9.2 Hospital-Acquired Disease Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nordion Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hospital-Acquired Disease Testing Market Competition, by Players
3.1 Global Hospital-Acquired Disease Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hospital-Acquired Disease Testing Players Market Share
3.2.2 Top 10 Hospital-Acquired Disease Testing Players Market Share
3.3 Market Competition Trend
4 Global Hospital-Acquired Disease Testing Market Size by Regions
4.1 Global Hospital-Acquired Disease Testing Revenue and Market Share by Regions
4.2 North America Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
4.5 South America Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
5 North America Hospital-Acquired Disease Testing Revenue by Countries
5.1 North America Hospital-Acquired Disease Testing Revenue by Countries (2013-2018)
5.2 USA Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
6 Europe Hospital-Acquired Disease Testing Revenue by Countries
6.1 Europe Hospital-Acquired Disease Testing Revenue by Countries (2013-2018)
6.2 Germany Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
6.3 UK Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
6.4 France Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hospital-Acquired Disease Testing Revenue by Countries
7.1 Asia-Pacific Hospital-Acquired Disease Testing Revenue by Countries (2013-2018)
7.2 China Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
7.5 India Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
8 South America Hospital-Acquired Disease Testing Revenue by Countries
8.1 South America Hospital-Acquired Disease Testing Revenue by Countries (2013-2018)
8.2 Brazil Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hospital-Acquired Disease Testing by Countries
9.1 Middle East and Africa Hospital-Acquired Disease Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Hospital-Acquired Disease Testing Revenue and Growth Rate (2013-2018)
10 Global Hospital-Acquired Disease Testing Market Segment by Type
10.1 Global Hospital-Acquired Disease Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Hospital-Acquired Disease Testing Market Forecast by Type (2018-2023)
10.3 UTI Testing Revenue Growth Rate (2013-2023)
10.4 SSI Testing Revenue Growth Rate (2013-2023)
10.5 Pneumococcal Infections Testing Revenue Growth Rate (2013-2023)
10.6 Bloodstream Infections Testing Revenue Growth Rate (2013-2023)
10.7 MRSA Testing Revenue Growth Rate (2013-2023)
11 Global Hospital-Acquired Disease Testing Market Segment by Application
11.1 Global Hospital-Acquired Disease Testing Revenue Market Share by Application (2013-2018)
11.2 Hospital-Acquired Disease Testing Market Forecast by Application (2018-2023)
11.3 Small and Medium Sized Hospitals Revenue Growth (2013-2018)
11.4 Large Sized Hospitals Revenue Growth (2013-2018)
12 Global Hospital-Acquired Disease Testing Market Size Forecast (2018-2023)
12.1 Global Hospital-Acquired Disease Testing Market Size Forecast (2018-2023)
12.2 Global Hospital-Acquired Disease Testing Market Forecast by Regions (2018-2023)
12.3 North America Hospital-Acquired Disease Testing Revenue Market Forecast (2018-2023)
12.4 Europe Hospital-Acquired Disease Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hospital-Acquired Disease Testing Revenue Market Forecast (2018-2023)
12.6 South America Hospital-Acquired Disease Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hospital-Acquired Disease Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Hospital-Acquired Disease Testing Picture
Table Product Specifications of Hospital-Acquired Disease Testing
Table Global Hospital-Acquired Disease Testing and Revenu
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
